During tumor progression, TTSPs such as matriptase, hepsin, and TMPRSS2 activate pro-HGF to elicit the HGF/c-MET pro-oncogenic/cell survival signaling pathway in vivo and/or in vitro28,33. Here, HGF is linked to neoplasm.